Table 2.
Outcomes of esomeprazole- and pantoprazole-based triple therapy.
| EAC group (n = 208) |
PAC group (n = 245) |
P value | |
|---|---|---|---|
| Eradication rate | |||
| Intention-to-treat | 72% (150/208) | 55% (135/245) | <.05 |
| Per-protocol | 91% (150/165) | 72% (135/187) | <.05 |
| Adverse events | 19% (39/208) | 17% (42/245) | .712 |
| Compliance | 87% (181/208) | 91% (223/245) | .083 |